As the most important component of bacterial endotoxin, LPS has been shown to aggravate metabolic disorders by elevating IL-1β, TNF-α, and IL-6 expression, which might be related to TLRs (Vaez et al., 2016). This evidence concerns the gene IL1B and metabolic disease.